Evidence map›Paper›PMID 42006949›Full record

ArticleFrontiers in aging neuroscience2026

Neuroanatomical patterns of dementia risk in autism spectrum disorder.

Young Seon Shin, Jingying Wang, Stormi L Pulver, Ann-Marie Orlando, Regilda A Romero, Carolina R Cuomo, Isabella Valiente Lauzan, Tyler Dentry, Desirae J Shirley, Danielle Christensen and 7 more

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Young Seon ShinLaboratory for Rehabilitation Neuroscience, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Jingying WangNeurocognitive and Behavioral Development Laboratory, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Stormi L PulverDepartment of Pediatrics, Emory School of Medicine, Atlanta, GA, United States.
Ann-Marie OrlandoCenter for Autism and Related Disabilities (CARD), University of Florida, Gainesville, FL, United States.
Regilda A RomeroUF Health Center for Autism and Neurodevelopment (UF Health CAN), University of Florida, Gainesville, FL, United States.
Carolina R CuomoNeurocognitive and Behavioral Development Laboratory, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Isabella Valiente LauzanLaboratory for Rehabilitation Neuroscience, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Tyler DentryLaboratory for Rehabilitation Neuroscience, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Desirae J ShirleyNeurocognitive and Behavioral Development Laboratory, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Danielle ChristensenNeurocognitive and Behavioral Development Laboratory, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Kathryn E UnruhLife Span Institute, Dole Human Development Center, University of Kansas, Lawrence, KS, United States.
Cassandra J StevensLife Span Institute, Dole Human Development Center, University of Kansas, Lawrence, KS, United States.
Walker S McKinneyDepartment of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Matthew W MosconiLife Span Institute, Dole Human Development Center, University of Kansas, Lawrence, KS, United States.
David E VaillancourtLaboratory for Rehabilitation Neuroscience, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Zheng WangNeurocognitive and Behavioral Development Laboratory, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.
Stephen A CoombesLaboratory for Rehabilitation Neuroscience, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, FL, United States.

Funding

Quantification of the neurocognitive, brain, and blood markers of dementia in middle-aged autistic adultsR01AG086493 · NIA · UNIVERSITY OF FLORIDA · PI Zheng Wang · 2024 to 2026
$2.0M
Advanced 3T for Structural and Functional Imaging at University of FloridaS10OD021726 · OD · UNIVERSITY OF FLORIDA · PI LONG, JOANNA R · 2017 to 2017
$2.0M
Cerebellar and Basal Ganglia Markers Underlie Neuromotor Impairments in Adults with Autism Spectrum Disorder (ASD)R01NS121120 · NINDS · UNIVERSITY OF FLORIDA · PI WANG, ZHENG · 2021 to 2025
$1.9M
NIA NIH HHS R01 AG086493NIH HHS S10 OD021726NINDS NIH HHS R01 NS121120
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder. While previous studies have reported a high prevalence of dementia diagnoses in the ASD population, the risk of dementia-related neurodegeneration remains poorly understood. This study aimed to assess dementia-sensitive composite measures of brain structure and brain age across the lifespan in an ASD cohort (ages 7-73) to investigate neuroanatomical features linked to neurodegenerative vulnerability. The composite score and brain age were not significantly different between diagnostic groups when analyses considered the entire cohort, nor when the cohort was split into subgroups based on age. However, age-effects were found for both groups, with negative relationships revealing a decrease in cortical thickness with increasing age. Subgroup analyses showed that the same negative relationship was evident in the old NT group but was absent in the old ASD group, even when controlling for clinical factors. Our findings are consistent with the safeguard or parallel development hypothesis and suggest that conventional dementia-like structural vulnerability is not widespread and generalizable in ASD. Our observations highlight the limitations of current dementia-sensitive composites in assessing neurodegenerative risk in ASD. Developing dementia-sensitive biomarkers for autistic individuals is critical to enhance diagnostic precision and identify clinically significant biomarkers in this cohort.

Indexed as

agingautism spectrum disordercortical thicknessdementiastructure MRI

Identifiers

PMID42006949
PMCPMC13082925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.